{"ticker": {"uuid": "39523f19-247f-44c6-b15a-4d28bd36d984", "symbol": "003060", "name": "Aprogen Biologics Inc.", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen, Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOVEk3UDZqclk0OFBQTllocGhWb0JpLUcwMnRLeTBzRVJhSUJHeFJMVEpKMGJOSEl5Z3NXVm04cnJJYV9vcURzTmRpLWg3aDVFM05XUzhTbm9IZlJyb0RWQ1R2cXFSWTY5cG93QnhTVWphUi1BMGZQN0hxSjFPa2Q3YnZXcTQ3MlEwZGpuZkVDeXlmb0xDdlFaek5DLUYxM1RkdXZQS2E4Zl9CVV85N3VSNG9BTENMRHYxbjNTM2pVSFZzVVdEdFl6czFWY016QURKTW03bEFKMEdfVE9vMS0wSThtdnhKdw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-13T22:00:00+00:00", "published_display": "13 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Aprogen Biologics \u2013 KRX:003060", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNZGlMd1hnYUg4TWVJbWVqRnN1dnpDYWlaVHl3ZGpPN1V0cVRzWllTRTJLbUpCVFlMM1Q1cDZBLWlyaUtTVmlCUDVteUdYbHdFd21hMHRrWDBmek56Nzl5TndZYXdmUXlfcl9ueEhLcVNOdkJCZEVXZUlMQUx0dUxPV1ByMTZaQ2hiTDZDU0xpb0ZsYjN4YnZkYlNDc2tSaFBk?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T08:46:12+00:00", "published_display": "11 Jul 2026 08:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen, Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxOVEk3UDZqclk0OFBQTllocGhWb0JpLUcwMnRLeTBzRVJhSUJHeFJMVEpKMGJOSEl5Z3NXVm04cnJJYV9vcURzTmRpLWg3aDVFM05XUzhTbm9IZlJyb0RWQ1R2cXFSWTY5cG93QnhTVWphUi1BMGZQN0hxSjFPa2Q3YnZXcTQ3MlEwZGpuZkVDeXlmb0xDdlFaek5DLUYxM1RkdXZQS2E4Zl9CVV85N3VSNG9BTENMRHYxbjNTM2pVSFZzVVdEdFl6czFWY016QURKTW03bEFKMEdfVE9vMS0wSThtdnhKdw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-13T22:00:00+00:00", "published_display": "13 Jul 2026 22:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Aprogen Biologics \u2013 KRX:003060", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNZGlMd1hnYUg4TWVJbWVqRnN1dnpDYWlaVHl3ZGpPN1V0cVRzWllTRTJLbUpCVFlMM1Q1cDZBLWlyaUtTVmlCUDVteUdYbHdFd21hMHRrWDBmek56Nzl5TndZYXdmUXlfcl9ueEhLcVNOdkJCZEVXZUlMQUx0dUxPV1ByMTZaQ2hiTDZDU0xpb0ZsYjN4YnZkYlNDc2tSaFBk?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T08:46:12+00:00", "published_display": "11 Jul 2026 08:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 37, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "guidance", "primary_label": "Guidance", "confidence": 58, "events": [{"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2085.0, "latest_week": "2026-07-10", "one_week_move": -1.0, "four_week_move": -19.0, "twelve_week_move": -44.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.88887, "market_dynamics_buy_signal": false, "relative_strength": -82.472269, "fair_value_gap": -87.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.8358, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.0% over one week, -19.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Guidance", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Guidance", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Guidance", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.0% over one week, -19.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Aprogen Biologics Inc. announced that it expects to receive KRW 2.000000772 billion in funding from Aprogen, Inc."}], "updated_at": "2026-07-17T17:50:46.700626+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}